Results 121 to 130 of about 42,089 (267)

Management of sacroiliac joint pain: current concepts. [PDF]

Eur J Orthop Surg Traumatol
Migliorini F, Lucenti L, Bardazzi T, Bell A, Cocconi F, Maffulli N.   +5 more
europepmc   +1 more source

Next‐generation proteomics improves lung cancer risk prediction

Molecular Oncology, EarlyView.
This is one of very few studies that used prediagnostic blood samples from participants of two large population‐based cohorts. We identified, evaluated, and validated an innovative protein marker model that outperformed an established risk prediction model and criteria employed by low‐dose computed tomography in lung cancer screening trials.
Megha Bhardwaj, Clara Frick, Ben Schöttker, Bernd Holleczek, Hermann Brenner   +4 more
wiley   +1 more source

Biology: The Open Road to a Theory of Life. [PDF]

Biology (Basel)
Moya A, Finne J.
europepmc   +1 more source

Potential therapeutic targeting of BKCa channels in glioblastoma treatment

Molecular Oncology, EarlyView.
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak, Karolina Pytlak, Sandra Jaworowska, Bogusz Kulawiak, Piotr Bednarczyk   +4 more
wiley   +1 more source

Long-term outcomes of arthroscopic management of femoroacetabular impingement syndrome: a systematic review. [PDF]

Arch Orthop Trauma Surg
Migliorini F, Vaishya R, Simeone F, Memminger MK, Betsch M, Pasurka M.   +5 more
europepmc   +1 more source

CT-based navigation for total hip arthroplasty: a meta-analysis. [PDF]

Eur J Med Res, 2023
Migliorini F, Cuozzo F, Oliva F, Eschweiler J, Hildebrand F, Maffulli N.   +5 more
europepmc   +1 more source

Book Reviews [PDF]

, 1952

core   +1 more source

Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib

Molecular Oncology, EarlyView.
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute, Júlia Huguet‐Pradell, Jordi Abril‐Fornaguera, Albert Gris‐Oliver, Alex Rialdi, Elisa Fernández‐Martínez, Carla Montironi, Vanessa Del Pozo, Peter Houghton, Laura Zanatto, Agavni Mesropian, Ieva Keraite, Swan Thung, Carolina Armengol, Pau Sancho‐Bru, Ernesto Guccione, Roser Pinyol, Josep M. Llovet   +17 more
wiley   +1 more source

Active and passive physical therapy in patients with chronic low-back pain: a level I Bayesian network meta-analysis. [PDF]

J Orthop Traumatol
Baroncini A, Maffulli N, Manocchio N, Bossa M, Foti C, Schäfer L, Klimuch A, Migliorini F.   +7 more
europepmc   +1 more source

ELEMENTARY SCIENCE OR GENERAL SCIENCE? [PDF]

School Science and Mathematics, 1917
openaire   +1 more source